Relay Therapeutics to Participate in Two Upcoming Investor Conferences

Rhea-AI Summary

Relay Therapeutics (Nasdaq: RLAY) will participate in two upcoming fireside chats: at the Goldman Sachs 42nd Annual Global Healthcare Conference on June 10, 2021, at 3:50 pm ET, and at the JMP Securities Life Science Conference on June 17, 2021, at 10:30 am ET. These discussions will be webcast live and accessible via the Investor page of Relay's website. Archived replays will be available for 90 days post-event. Relay Therapeutics, a clinical-stage precision medicine company, aims to enhance drug discovery using its Dynamo™ platform focused on oncology and genetic diseases.

CAMBRIDGE, Mass., June 02, 2021 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY) is scheduled to participate in fireside chats at the Goldman Sachs 42^nd Annual Global Healthcare Conference on Thursday, June 10, 2021 at 3:50 pm ET and at the JMP Securities Life Science Conference on Thursday, June 17, 2021 at 10:30 am ET. The fireside chats will be webcast live and may be accessed from the Investor page of Relay Tx’s website under Events and Presentations. Within 24 hours following each fireside chat, an archived replay of the webcast will be available for 90 days.

About Relay Therapeutics

Relay Therapeutics (Nasdaq: RLAY) is a clinical-stage precision medicines company transforming the drug discovery process with the goal of bringing life-changing therapies to patients. Relay Therapeutics is the first of a new breed of biotech created at the intersection of disparate disciplines. The company’s Dynamo™ platform integrates an array of leading-edge computational and experimental approaches to effectively drug protein targets that have previously been intractable. The initial focus is on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease. For more information, please visit www.relaytx.com or follow us on Twitter.

Contact:
Pete Rahmer
Senior Vice President, Corporate Affairs and Investor Relations
617-322-0715
prahmer@relaytx.com 

Media:
Dan Budwick
1AB
973-271-6085
dan@1abmedia.com 

FAQ

When is Relay Therapeutics participating in the Goldman Sachs Healthcare Conference?

Relay Therapeutics will participate in the Goldman Sachs 42nd Annual Global Healthcare Conference on June 10, 2021, at 3:50 pm ET.

What is the date for Relay Therapeutics' participation in the JMP Securities Life Science Conference?

Relay Therapeutics will be at the JMP Securities Life Science Conference on June 17, 2021, at 10:30 am ET.

How can I access the webcast of Relay Therapeutics' fireside chats?

The fireside chats can be accessed live from Relay Therapeutics' Investor page on their website.

Will there be a replay available for Relay Therapeutics' fireside chats?

Yes, an archived replay of each fireside chat will be available for 90 days after the event.

What is Relay Therapeutics' focus in drug development?

Relay Therapeutics focuses on enhancing small molecule therapeutic discovery in targeted oncology and genetic diseases.